A 2-Part, Multicenter, Randomized, Blinded, Active-Controlled Phase 2 Study to Sequentially Evaluate the Safety and Efficacy of BIIB091 Monotherapy and BIIB091 Combination Therapy With Diroximel Fumarate in Participants With Relapsing Forms of Multiple Sclerosis
Details
Age
Adult
Locations
Brain Imaging Center (BIC)
Outpatient CTRC
Principal Investigator
Enrique Alvarez
Study ID
Protocol Number: 22-2421
More information available at ClinicalTrials.gov: NCT05798520
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers